FAQ

FAQ published on January 11, 2016
Join Bruce D. Cheson, MD, in this Managing HL FAQ as he describes the strategies that can be utilized to accurately diagnose Hodgkin lymphoma in areas that lack adequate pathology.
FAQ published on August 12, 2015
Dr. Richard Hoppe explains the key issues in the NCCN Guidelines related to imaging patients with Hodgkin lymphoma.
FAQ published on August 12, 2015
Dr. Richard Hoppe discusses the impact of the updated Lugano Classification System for Hodgkin and Non-Hodgkin Lymphomas on today's practicing clinicians.
FAQ published on August 3, 2015
Dr. Richard Hoppe discusses the important conclusions practicing clinicians should be aware of in regards to the recently published NCCN Hodgkin Lymphoma Guidelines.
FAQ published on August 3, 2015
Dr. Richard Hoppe discusses the most significant updates to the recently published NCCN Hodgkin Lymphoma Guidelines.
FAQ published on July 1, 2015
Dr. Anas Younes briefly describes the ways in which the management of Hodgkin lymphoma is evolving.
FAQ published on July 1, 2015
Dr. Anas Younes briefly describes the current options available to patients who have undergone ASCT and are experiencing disease relapse.
FAQ published on November 19, 2014
Dr. Bjorkholm discusses how similar Swedish trends are versus other European countries.
FAQ published on November 5, 2014
Dr. Borchmann discusses the use of PET response to determine treatment intensity and predict patient prognosis.
FAQ published on October 28, 2014
Dr. Björkholm discusses survival trends from his large cohort study in Sweden.
Page 3 of 6
Results 21 - 30 of 58

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved